An LC-MS toolbox for identifying and guiding the development of cysteine-targeted small molecule covalent inhibitors
Baltier, Erickson, Kunz, Braun and Erickson. AACR Annual Meeting 2025, Chicago. See the poster
Find what your compound hits, measure how much of your target it engages, and confirm the answer with a second, independent LC-MS method, all in one lab.
Global cysteine profiling measures competitive reactivity across about 20,000 reactive cysteine sites per experiment. It reveals selectivity and finds the targets of phenotypic hits.
Targeted assays with heavy internal standards quantify engagement precisely, and still resolve it above 99%.
Every cysteine measurement can be paired with a protein-level measurement from the same sample, separating true engagement from a protein that is simply changing in abundance.
Methods
Each method answers a different question, and each suits a different point in a program.
What it measures
Competitive labeling of cysteines across the whole proteome, read out by TMT.
Best for
Screening libraries, mapping selectivity, and finding the target of a phenotypically active compound.
What it measures
The unmodified target peptide disappearing, tracked by a PRM panel with heavy standards against stable control peptides.
Best for
Routine, sensitive engagement readouts, including in clinically relevant matrices.
What it measures
The compound–peptide adduct itself, as a fraction of total target peptide signal.
Best for
Confirming engagement directly, including near-complete engagement.
Why run more than one
Many providers offer one of these approaches. We run all three on the same system, so each result can be checked against the others.
In our sotorasib work, the directly measured adduct fraction matched the engagement inferred from loss of the unmodified peptide. Once two independent methods agree, the faster indirect assay can carry the rest of a program with confidence.
Direct and indirect, cross-checked: two readouts, one answer.
Case study
We ran all three methods on sotorasib, the KRAS G12C inhibitor, in H358 cells. Baltier et al., AACR 2025.
01 · Global cysteine profiling
Six doses in triplicate fit in one TMT 18‑plex, quantifying more than 8,000 cysteine peptides. The KRAS G12C cysteine peptide disappeared with dose while the KRAS protein held flat, so the loss reflects engagement, not degradation.
A cysteine peptide on vimentin (C328) also dropped with dose and looked like an off-target hit. The companion proteome showed the vimentin protein itself was changing, which ruled it out.


02 · Targeted engagement
The directly measured adduct fraction tracked the engagement inferred from loss of the unmodified peptide. Engagement above 99% was still resolved, across a 4-log linear range.
Isoforms are the hard part. Peptides shared across RAS isoforms moved with dose, while the KRAS-unique peptide SFEDIHHYR held steady. Normalizing to that unique peptide is what makes the engagement number trustworthy.

How it works
Everything runs in 96-well format, with on-deck lysis and automated liquid handling, in our Framingham laboratory.
Cells treated across your dose series. Cell culture available in house.
Proteins extracted under native conditions, with Covaris on-deck lysis. We recommend sending cell pellets; lysates are also accepted.
Cysteines left free by your compound capped with desthiobiotin-iodoacetamide.
Each sample digested and TMT-labeled, then pooled into one 18‑plex.
Our edge
Two streams from one sample:
LC-MS on our Orbitrap platforms, then quantification, QC and a report.
Specifications
Evidence
Baltier, Erickson, Kunz, Braun and Erickson. AACR Annual Meeting 2025, Chicago. See the poster
Simanshu DK, et al. Read more
Canon J, et al. Read more
Thirty peer-reviewed papers draw on data from our laboratory. See all publications, or read our technical note, Covalent inhibitor profiling.
Working with us
We help design the dose series, plexing scheme, replicates and controls before any sample is committed.
Ship Monday to Wednesday, overnight on dry ice, with the submission form.
Preparation, enrichment, acquisition and analysis all run in our Framingham laboratory. Nothing is subcontracted.
Processed tables, a methods and summary report, and a consultation on what the data shows.
Tell us about your compound, target and samples. We’ll recommend the right method, or combination, before any sample is committed.